MAUREEN KOZLOW: Open Payments
NPI 1659040020 · HOBART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 48 payments from 14 companies in 2025. Trend: 2023 $1,436 · 2024 $1,236 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $215 |
| Amgen Inc. | 12 | $193 |
| Novo Nordisk Inc | 9 | $144 |
| Merck Sharp & Dohme LLC | 4 | $95 |
| Boston Scientific Corporation | 1 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $33 |
| Lilly USA, LLC | 2 | $32 |
| Abbott Laboratories | 1 | $27 |
Products named: REPATHA, CAMZYOS, Wegovy, WATCHMAN FLX, VERQUVO, LEQVIO, JARDIANCE, Kerendia.
Industry payments across IN — which companies pay providers there.
